BeStock  
Markets › Compare › SYRE vs RAL

SYRE vs RAL

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SYRE · Spyre Therapeutics$92.72 ▼ 0.50%
RAL · Ralliant$73.96 ▲ 1.04%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

52218384550715Oct 7, '25Apr 7, '26Oct 5, '26
  • SYRE +478.8%
  • RAL +69.4%

Head to head

MetricSYRERAL
Price$92.72$73.96
Change today▼ 0.50%▲ 1.04%
Market cap$8.18B$8.18B
Return, 3 months-1.6%+9.3%
Return, year to date+183.0%+45.7%
Return, 1 year+456.2%+68.8%
P/E (TTM)-46.8-6.6
P/B8.65.3
P/E percentile vs own 5y––
Dividend yield–0.27%
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)5371
30-day volatility52.0%31.2%
Max drawdown, 1 year-22.2%-31.8%
Trend readStrong uptrendStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • RAL is the largest of the group by market value.
  • SYRE has returned the most over the past year.
  • SYRE carries the lowest trailing P/E.
  • RAL has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top